A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot–Marie–Tooth disease type 1
- DOI
- 10.1093/stcltm/szag048
- Published
- 2026-07-20
- Container
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/stcltm/szag048,
title = {A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot–Marie–Tooth disease type 1},
author = {Hyesun Kim and Byung-Ok Choi and Hyunju Lee and Saeyoung Park and Jaeseung Lim and Sung-Chul Jung},
year = {2026},
journal = {Stem Cells Translational Medicine},
doi = {10.1093/stcltm/szag048},
url = {https://doi.org/10.1093/stcltm/szag048}
}RIS
TY - JOUR TI - A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot–Marie–Tooth disease type 1 AU - Hyesun Kim AU - Byung-Ok Choi AU - Hyunju Lee AU - Saeyoung Park AU - Jaeseung Lim AU - Sung-Chul Jung PY - 2026 JO - Stem Cells Translational Medicine DO - 10.1093/stcltm/szag048 UR - https://doi.org/10.1093/stcltm/szag048 ER -
APA
Kim, H., Choi, B., Lee, H., Park, S., Lim, J., & Jung, S. (2026). A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot–Marie–Tooth disease type 1. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szag048
Source records
- crossref · retrieved 2026-09-26T11:44:14.487Z